yvandenbroek
/
sprookjes
/
Login
Register
TriplyDB
sprookjes
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
2
Q41536996-BD9A7BC2-AEEA-4183-BF79-869CD85EBEB9
Q41536996-BD9A7BC2-AEEA-4183-BF79-869CD85EBEB9
BestRank
Statement
http://www.wikidata.org/entity/statement/Q41536996-BD9A7BC2-AEEA-4183-BF79-869CD85EBEB9
Nab-Paclitaxel in combination with Cisplatin Versus Docetaxel Plus Cisplatin as First-Line Therapy in Non-small Cell Lung Cancer
P2860
Q41536996-BD9A7BC2-AEEA-4183-BF79-869CD85EBEB9
BestRank
Statement
http://www.wikidata.org/entity/statement/Q41536996-BD9A7BC2-AEEA-4183-BF79-869CD85EBEB9
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
b1b3272d276b31645f5063b51ae1bdca099311fa
P2860
Efficacy and safety of weekly nab-paclitaxel plus carboplatin in patients with advanced non-small cell lung cancer.